Innovation in the pharmaceutical industry

Journal of the Royal Society of Medicine

Volumn 93, Issue 7, 2000, Pages 341-345

  Horrobin, David F ^a  

^a Laxdale Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; DERMATOLOGICAL AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; ESTROGEN; FLUOXETINE; FOLIC ACID; HISTAMINE H2 RECEPTOR ANTAGONIST; NORADRENALIN; OMEPRAZOLE; OXYTOCIN; PROSTAGLANDIN; SEROTONIN UPTAKE INHIBITOR; THYROID HORMONE; UNSATURATED FATTY ACID;

CHEMISTRY; COMPUTER AIDED DESIGN; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; DEPRESSION; DRUG COST; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; GENE THERAPY; NOTE; ORGANIZATION; PHARMACOGENOMICS; PRODUCTIVITY; RESEARCH; SCREENING;

EID: 0033941034     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/014107680009300702     Document Type: Note

References (13)

1. 1 Ansell J. Converging Targets: R&D Strategies of the Top 20 Pharmaceutical Companies. Thame: Decision Resources, October 1997
2. 2 Östholm I. Drug Discovery: a Pharmacist's Story. Stockholm: Swedish Pharmaceutical Press, 1995
3. 3 Lahana R. How many leads from HTS. Drug Discov Today 1999;4:447-8
4. 4 Loftus P. Quoted in: Brown P. Has R&D failed the pharmaceutical industry? Scrip Magazine 1994;July/August: 3-4
5. 5 Drews J, ed. In Quest of Tomorrow's Medicine (transl D Kramer). New York: Springer-Verlag, 1999
6. 6 Butler D. IBM promises scientists 500-fold leap in supercomputing power . . . Nature 1999;402:705-6
7. 7 Witt MR, Nielsen M. Characterisation of the influence of unsaturated free fatty acids on brain GABA/benzodiazepine receptor binding in vitro. J Neurochem 1994;62:1432-9
8. 8 Horrobin DF. Development of agonist drugs. J Pharm Med 1991;2:69-80
9. 9 Horrobin DF. The philosophical basis of drug target selection. Pharm Med 1996;10:29-42
10. 10 Botez M, Young SN, Bachevalier J, Gauthier S. Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat. Nature 1979;278:182-3
11. 11 Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised placebo-controlled trial. J Affect Disord (in press)
12. 12 Freedman SD, Katz MH, Parker EM, Laposata M, Urman MY, Alvarez JG. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/+) mice. Proc Natl Acad Sci USA 1999;96:3995-4000
13. 13 Vaddadi K. Essential fatty acids and movement disorders. In: Peet M, Glen I, Horrobin DF, eds. Phospholipid Spectrum Disorder in Psychiatry. Carnforth: Marius Press, 1999:285-95